Objective To compare the efficacy and toxicities of docetaxel plus epirubicin in the neoadjuvant chemotherapy of patients with triple negative breast cancer and non-triple negative breast cancer. Methods One hundred and seventy-two patients with breast cancer were treated with docetaxel plus epirubicin ne...